Nagano, Japan

Yuji Hoyano

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 2007-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Hoyano. Retrieved from https://idiyas.com/inventor/yuji-hoyano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yuji Hoyano: Innovator in Pharmaceutical Chemistry

Introduction

Yuji Hoyano is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 4 patents to his name, Hoyano continues to push the boundaries of medical science.

Latest Patents

Hoyano's latest patents include groundbreaking work on 5-amidino-2-hydroxybenzenesulfonamide derivatives. These derivatives are crucial for developing pharmaceutical compositions and intermediates for their preparation. Additionally, he has developed agents for the prevention or treatment of renal diseases, which utilize the same 5-amidino-2-hydroxybenzenesulfonamide derivatives as active ingredients.

Career Highlights

Hoyano is currently associated with Kissei Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing treatments for various medical conditions, particularly those related to renal health.

Collaborations

Some of his notable coworkers include Kosuke Okazaki and Masahiko Uchida. Their collaborative efforts have further enhanced the innovative research environment at Kissei Pharmaceutical.

Conclusion

Yuji Hoyano's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patents not only reflect his expertise but also hold the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…